Fulcrum Therapeutics (FULC) Current Leases (2019 - 2025)
Historic Current Leases for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $2.3 million.
- Fulcrum Therapeutics' Current Leases rose 1002.81% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 1002.81%. This contributed to the annual value of $2.2 million for FY2024, which is 27.37% down from last year.
- According to the latest figures from Q3 2025, Fulcrum Therapeutics' Current Leases is $2.3 million, which was up 1002.81% from $2.3 million recorded in Q2 2025.
- In the past 5 years, Fulcrum Therapeutics' Current Leases registered a high of $2.7 million during Q1 2023, and its lowest value of $469000.0 during Q1 2021.
- In the last 5 years, Fulcrum Therapeutics' Current Leases had a median value of $2.2 million in 2025 and averaged $1.9 million.
- Per our database at Business Quant, Fulcrum Therapeutics' Current Leases surged by 45479.74% in 2022 and then plummeted by 2369.51% in 2024.
- Over the past 5 years, Fulcrum Therapeutics' Current Leases (Quarter) stood at $469000.0 in 2021, then surged by 454.8% to $2.6 million in 2022, then dropped by 15.76% to $2.2 million in 2023, then dropped by 0.27% to $2.2 million in 2024, then rose by 7.41% to $2.3 million in 2025.
- Its Current Leases stands at $2.3 million for Q3 2025, versus $2.3 million for Q2 2025 and $2.2 million for Q1 2025.